E11.9

Type 2 diabetes mellitus without complications

## Clinical Overview Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from a combination of resistance to insulin action and an inadequate compensatory insulin secretory response. The code E11.9 specifically denotes type 2 diabetes mellitus without complications, meaning that at the time of the clinical encounter, the patient does not manifest documented secondary chronic conditions such as retinopathy, nephropathy, neuropathy, or peripheral vascular disease directly attributed to their diabetes. While the absence of complications is noted, T2DM remains a progressive disease that requires diligent management to prevent future morbidity. It is the most common form of diabetes, accounting for approximately 90 to 95 percent of all diagnosed cases of diabetes in adults. ## Pathophysiology The primary defect in T2DM is the body's ineffective use of insulin, known as insulin resistance. Initially, the pancreas compensates by increasing insulin production (hyperinsulinemia). Over time, the pancreatic beta cells become exhausted and are unable to maintain sufficient insulin levels to overcome the resistance, leading to persistent hyperglycemia. This metabolic derangement is often associated with obesity, particularly visceral adiposity, which releases free fatty acids and inflammatory cytokines that further impair insulin sensitivity in the liver, skeletal muscle, and adipose tissue. Additionally, there is often a lack of suppression of glucagon secretion from alpha cells, further contributing to elevated glucose levels. ## Diagnostic Criteria The diagnosis of type 2 diabetes mellitus is established using standardized glycemic markers. According to current clinical guidelines, a patient is diagnosed with T2DM if they meet any of the following criteria: a hemoglobin A1c (HbA1c) level of 6.5 percent or higher; a fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher; or a two-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a standardized oral glucose tolerance test (OGTT). In cases where the patient exhibits classic symptoms of hyperglycemia or a hyperglycemic crisis, a random plasma glucose of 200 mg/dL or higher is also diagnostic. It is standard practice to confirm the diagnosis with a repeat test on a separate day unless clinical symptoms are overt. ## Management and Standard of Care The primary goal of managing E11.9 is to maintain glycemic control to prevent the onset of microvascular and macrovascular complications. The standard of care begins with therapeutic lifestyle changes, including medical nutrition therapy focused on portion control and carbohydrate quality, alongside regular physical activity (at least 150 minutes of moderate-intensity exercise per week). Pharmacological intervention often starts with Metformin, which decreases hepatic glucose production and improves insulin sensitivity. Regular monitoring of HbA1c (typically every 3 to 6 months) is essential. Even when coded as without complications, patients must undergo annual screenings, including dilated eye exams, comprehensive foot examinations, and urine albumin-to-creatinine ratio (UACR) assessments to ensure that any emerging complications are identified and treated early. Blood pressure and lipid management are also critical components of the holistic care plan for these patients.

Clinical Symptoms

  • Increased thirst (polydipsia)
  • Frequent urination (polyuria)
  • Increased hunger (polyphagia)
  • Unintended weight loss
  • Fatigue
  • Blurred vision
  • Slow-healing sores
  • Frequent infections
  • Areas of darkened skin (acanthosis nigricans)
  • Asymptomatic presentation (common in early stages)

Common Causes

  • Insulin resistance
  • Excess body weight and obesity
  • Physical inactivity
  • Genetics and family history of diabetes
  • Age (45 years or older)
  • Ethnicity (higher risk in certain populations)
  • History of gestational diabetes
  • Polycystic ovary syndrome (PCOS)
  • Non-alcoholic fatty liver disease

Documentation & Coding Tips

Distinguish between without complications and unspecified complications.

Example: Patient with Type 2 diabetes mellitus presents for routine management. Current A1c is 6.8 percent. Comprehensive physical examination reveals no evidence of diabetic peripheral neuropathy, retinopathy, or nephropathy. Patient is currently managed with Metformin 1000mg BID and lifestyle modifications. Diagnosis: Type 2 diabetes mellitus without complications (E11.9). Plan: Continue current regimen, repeat A1c in 6 months.

Billing Focus: Identify the absence of any manifestations or end-organ damage to justify the use of E11.9 rather than a more specific complication code.

Document current medication status and adherence.

Example: Type 2 diabetes mellitus, stable and without complications. Patient is adherent to oral hypoglycemic therapy (Metformin). No signs of hypoglycemia or hyperglycemic crisis. A1c remains at goal of less than 7.0. Billing includes Z79.84 for long-term use of oral hypoglycemic drugs.

Billing Focus: Use Z-codes (Z79.84 for oral agents, Z79.4 for insulin) as secondary codes to support the medical necessity of monitoring and management.

Report body mass index (BMI) and associated obesity.

Example: 65-year-old male with Type 2 diabetes mellitus without complications. BMI is 32.4, classified as Class I Obesity. Counseling provided on weight loss and exercise to improve glycemic control. Coding includes E11.9 and E66.9 with BMI code Z68.32.

Billing Focus: Explicitly link BMI and obesity to the diabetes management plan to support additional complexity.

Include screening results to prove the absence of complications.

Example: Follow-up for Type 2 diabetes. Monofilament test negative for loss of protective sensation. Fundoscopic exam shows no hemorrhages or exudates. Spot urine albumin-to-creatinine ratio is within normal limits at 15 mg/g. E11.9 is confirmed as no chronic complications are present at this time.

Billing Focus: Detailed negative findings justify the specificity of the without complications suffix.

Clarify the type of diabetes (Type 2 vs. Type 1 or Secondary).

Example: Patient with long-standing Type 2 diabetes mellitus, diagnosed 10 years ago. No evidence of insulin resistance or ketoacidosis. Condition is managed without insulin. Currently stable without manifestations (E11.9). This is not Type 1 diabetes (E10.-) or secondary diabetes (E08-E13).

Billing Focus: Ensuring the code reflects the correct etiology (Type 2) prevents billing denials related to incorrect diagnostic categories.

Relevant CPT Codes

Related Diagnoses

Hierarchy